Venture Capital: Gene Engineering Platform Poseida Therapeutics Raises $110M in Series D Round

June 26, 2020 | News, Venture Capital

Poseida filed for an IPO worth $115 million on June 19.

Within a few days of filing an S-1 registration statement to raise $115 million via an IPO of its common stock, Poseida Therapeutics has switched tracks and opted to raise $110 million in a Series D round. Fidelity Management and Research Co. led the round with participation from Adage Capital Management and Schonfeld Strategic Advisors. Several unnamed existing investors also participated. (Crunchbase)

Poseida had filed to go public previously in January 2019. However, it withdrew the IPO after raising $142 million in a Series C round. That round, in April 2019, was led by Novartis (SWX: NOVN).

Dublin-listed life-sciences investment group Malin did not participate in this round. Malin Life Sciences acquired a 33% stake in Poseida in 2015 in a deal valued at $30 million.

The gene therapy company’s aggregate fundraise to date is $336.5 million.

Cancer therapies

San Diego based Poseida is developing a portfolio of genetic and CAR-T-based therapies for blood, solid, and other cancers.

“This financing supports the approach we are taking to leverage our broad proprietary gene engineering platform technologies, including the piggyBac DNA Modification System and Cas-CLOVER site-specific gene-editing system, for the creation of numerous differentiated cell and gene therapy product candidates,” Poseida’s CEO Eric Ostertag, M.D., Ph.D., said in a written statement.

Currently, Poseida’s P-BCMA-101, a CAR-T treatment for patients with multiple myeloma, is in Phase 2 clinical trials. All other drug candidates are in preclinical stages.

Proceeds from the financing will primarily fund the company’s ongoing clinical trials, and also be used for further research and development.

Related Story:   Daphne Koller Raises $143M For Insitro, Her AI-Bio Startup                                                

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
Venture Capital: Health Data Analytics Platform Evidation Raises $45M
July 2, 2020     News, Venture Capital

Evidation Health’s Achievement platform collects everyday health data for use in innovative research and health platforms. Giving due emphasis to user privacy and controlled, permissioned health data, the platform gathers…
Artificial Intelligence: A UVC Robot Disinfects 4,000 Sq Ft Food Bank in 30 Minutes
July 2, 2020     Artificial Intelligence, News

MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL), Ava Robotics, and the Greater Boston Food Bank (GBFB) collaborated on a robotic solution to the problem of disinfecting a large area…
Alternative Investments: TrueMark Investments Launches A Structured Outcome ETF That Tracks the S&P 500 Index
July 2, 2020     Alternative Investments, News

TrueMark Investments has launched the TrueShares Structured Outcome (July) ETF (NYSEAMERICAN: JULZ) that offers investors exposure to the S&P 500 price index. The ETF is a “structured outcome” product, the…
Digital Assets: Crypto Gathers Pace in India After Top Court Decision
July 2, 2020     Digital Assets, News

The Supreme Court of India recently struck down a circular issued by the Reserve Bank of India that barred banks from serving crypto businesses such as traders, exchanges, or others….